Merck gave a “state of the biz-nass” presentation today. Here’s their statement about it. As with every other major pharma company, they plan to
- develop more vaccines and biologic drugs
- sell more in emerging markets like India and China
- use “diversity” when they mean “diversification”
My favorite statement was this sentence on the company’s “focus”:
The Company is focused on developing novel, best-in-class or follow-on treatments for patients in primary care, specialty care, and hospital settings.
That is, they’re “focused” on making all types of drugs for all settings.